CryoLife, Inc. CRY

CryoLife, Inc. Total Assets 2011-2026 | CRY

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets CryoLife, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
789 M	606 M	571 M	590 M	316 M	181 M	176 M	175 M	157 M	148 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
789 M	148 M	371 M

Total Assets of other stocks in the Medical devices industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
Alphatec Holdings ATEC	791 M	$ 11.75	-3.29 %	$ 1.76 B	USA
BioSig Technologies BSGM	842 K	-	37.08 %	$ 85.7 M	USA
GenMark Diagnostics, Inc. GNMK	224 M	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	659 M	-	-	$ 3.31 B	USA
Delcath Systems DCTH	124 M	$ 8.98	-1.32 %	$ 322 M	USA
Aziyo Biologics AZYO	62.4 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	54 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	10.6 M	-	-5.86 %	$ 30.6 M	USA
Second Sight Medical Products EYES	41.6 M	-	-0.97 %	$ 54.4 M	USA
FONAR Corporation FONR	199 M	$ 18.41	0.38 %	$ 121 M	USA
Conformis CFMS	94 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	323 M	-	0.15 %	$ 844 M	USA
Inogen INGN	299 M	$ 6.32	-2.02 %	$ 168 M	USA
Apollo Endosurgery APEN	110 M	-	-	$ 475 M	USA
IRIDEX Corporation IRIX	34.4 M	$ 1.35	-	$ 21.8 M	USA
IRadimed Corporation IRMD	109 M	$ 100.97	1.78 %	$ 1.28 B	USA
Avinger AVGR	13.8 M	-	-20.74 %	$ 369 K	USA
LivaNova PLC LIVN	2.61 B	$ 62.4	-1.33 %	$ 3.4 B	Britain
LENSAR LNSR	66.3 M	$ 5.56	-8.4 %	$ 64 M	USA
AxoGen AXGN	222 M	$ 32.61	2.71 %	$ 1.5 B	USA
CONMED Corporation CNMD	2.33 B	$ 36.56	-0.19 %	$ 1.13 B	USA
Medtronic PLC MDT	91.7 B	$ 86.58	-0.68 %	$ 111 B	USA
Soliton, Inc. SOLY	33.8 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	10.5 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	64.1 M	-	0.03 %	$ 1.58 B	Israel
NanoVibronix NAOV	3.63 M	-	-	$ 1.08 M	USA
Electromed ELMD	53.8 M	$ 24.7	0.86 %	$ 209 M	USA
Misonix, Inc. MSON	204 M	-	-	$ 462 M	USA
Neovasc NVCN	66.2 M	-	-	$ 111 M	Canada
InspireMD NSPR	69.4 M	$ 1.79	3.47 %	$ 115 M	Israel
Orthofix Medical OFIX	851 M	$ 11.72	-1.26 %	$ 464 M	Curacao
Intersect ENT, Inc. XENT	227 M	-	-	$ 955 M	USA
Cytosorbents Corporation CTSO	47.4 M	$ 0.7	3.3 %	$ 38.1 M	USA
Aethlon Medical AEMD	7.36 M	$ 2.16	-6.09 %	$ 3.37 M	USA
Profound Medical Corp. PROF	43.9 M	$ 5.15	-4.63 %	$ 180 M	Canada
BIOLASE BIOL	35.1 M	-	-13.19 %	$ 166 K	USA
Penumbra PEN	1.83 B	$ 334.17	-0.41 %	$ 13 B	USA
AdaptHealth Corp. AHCO	4.32 B	$ 11.48	10.7 %	$ 1.55 B	USA
Myomo MYO	38.6 M	$ 0.7	-1.83 %	$ 29.3 M	USA
Insulet Corporation PODD	3.19 B	$ 225.5	-0.7 %	$ 15.9 B	USA
Nano-X Imaging Ltd. NNOX	210 M	$ 2.4	-1.64 %	$ 141 M	Israel
Invacare Corporation IVC	771 M	-	-	$ 24.7 M	USA
EDAP TMS S.A. EDAP	86.1 M	$ 3.91	4.83 %	$ 146 M	France
Quanterix Corporation QTRX	419 M	$ 3.82	-3.05 %	$ 163 M	USA
OrthoPediatrics Corp. KIDS	509 M	$ 15.91	-3.4 %	$ 373 M	USA
Outset Medical OM	264 M	$ 3.53	-2.35 %	$ 53.7 K	USA